US Patent 7122662 Tricyclic compound having spiro union
Patent 7122662 was granted and assigned to Mochida Pharmaceutical on October, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+319 characters)
Article
Patent abstract
This invention relates to tricyclic compounds having spiro union represented by the following formula (I) or its salt which is useful as a drug, and in particular, as an inhibitor for activated blood coagulation factor X, which can be administered orally and which exhibits strong anticoagulation action.
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07122662 Tricyclic compound having spiro union US Patent 7122662 Tricyclic compound having spiro union
Infobox
Patent Number
0712266200
Patent Number
712266200
Edits on 23 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071226620
Date of Patent
October 17, 2006
0Patent Application Number
110123780
Date Filed
December 16, 2004
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071226620
Date of Patent
October 17, 2006
0Patent Application Number
110123780
Date Filed
December 16, 2004
0Official Website
Patent Primary Examiner
Edits on 7 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 18 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07122662 Tricyclic compound having spiro union
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07122662
Date of patent
October 17, 2006
Patent application number
11012378
Date Filed
December 16, 2004
Patent primary examiner
Find more entities like US Patent 7122662 Tricyclic compound having spiro union
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
